Treace Medical Concepts, Inc. financial data

Symbol
TMCI on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
100 Palmetto Park Place, Ponte Vedra, FL
State of incorporation
FL
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Feb 27, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 412 % -32.9%
Quick Ratio 97.2 % +19.2%
Debt-to-equity 97 % +38.7%
Return On Equity -48.9 % -43.9%
Return On Assets -24.8 % -24.1%
Operating Margin -26.6 % +3.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 62.6M shares +0.99%
Common Stock, Shares, Outstanding 62.3M shares +1.09%
Entity Public Float 310M USD -74.7%
Common Stock, Value, Issued 62K USD 0%
Weighted Average Number of Shares Outstanding, Basic 62.1M shares +2.07%
Weighted Average Number of Shares Outstanding, Diluted 62.1M shares +2.07%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 209M USD +11.9%
Research and Development Expense 20.6M USD +33.3%
Selling and Marketing Expense 148M USD +4.79%
General and Administrative Expense 55.7M USD +18.5%
Operating Income (Loss) -55.7M USD -8.28%
Net Income (Loss) Attributable to Parent -55.7M USD -12.6%
Earnings Per Share, Basic -0.9 USD/shares -11.1%
Earnings Per Share, Diluted -0.9 USD/shares -11.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 11.4M USD -12.6%
Marketable Securities, Current 64.3M USD -41.6%
Accounts Receivable, after Allowance for Credit Loss, Current 40.8M USD +7.2%
Inventory, Net 39.3M USD +34.2%
Assets, Current 161M USD -18.6%
Property, Plant and Equipment, Net 26M USD +16.4%
Operating Lease, Right-of-Use Asset 8.44M USD -8.87%
Intangible Assets, Net (Excluding Goodwill) 8.08M USD -10.5%
Goodwill 12.8M USD 0%
Other Assets, Noncurrent 407K USD +179%
Assets 217M USD -13.8%
Accounts Payable, Current 10.5M USD -11.1%
Employee-related Liabilities, Current 6.58M USD -12.9%
Accrued Liabilities, Current 7.2M USD -31.2%
Liabilities, Current 34.9M USD -22.4%
Operating Lease, Liability, Noncurrent 15.9M USD +0.27%
Other Liabilities, Noncurrent 37K USD 0%
Liabilities 104M USD -8.57%
Accumulated Other Comprehensive Income (Loss), Net of Tax 97K USD -40.5%
Retained Earnings (Accumulated Deficit) -190M USD -41.5%
Stockholders' Equity Attributable to Parent 113M USD -18.2%
Liabilities and Equity 217M USD -13.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -7.22M USD +58.2%
Net Cash Provided by (Used in) Financing Activities -185K USD -100%
Net Cash Provided by (Used in) Investing Activities 3.76M USD
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 62.4M shares +1.03%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -3.65M USD -136%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 11.4M USD -12.6%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.32M USD +2.49%
Deferred Tax Assets, Valuation Allowance 44.1M USD +25.4%
Deferred Tax Assets, Gross 49.3M USD +26.2%
Operating Lease, Liability 16.3M USD -5.48%
Payments to Acquire Property, Plant, and Equipment 3.93M USD +166%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -55.8M USD -13.1%
Lessee, Operating Lease, Liability, to be Paid 23.3M USD -9.64%
Property, Plant and Equipment, Gross 41.3M USD +32.9%
Operating Lease, Liability, Current 413K USD -70.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 3.34M USD +139%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.82M USD -37.3%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 6.91M USD -18.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 3.1M USD -7.25%
Deferred Tax Assets, Operating Loss Carryforwards 28.2M USD +22.8%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 3.16M USD +2%
Additional Paid in Capital 303M USD +11.4%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 200K USD
Depreciation, Depletion and Amortization 1.91M USD +107%
Deferred Tax Assets, Net of Valuation Allowance 5.12M USD +34.2%
Share-based Payment Arrangement, Expense 30.6M USD +76.4%
Interest Expense 5.26M USD +1.72%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%